Patients should consult medical providers before using alternative delivery systems
For the starting dose phase (2 mg per week), 5 mg/mL or 10 mg/mL both work well
The latest updates in clinical research, including the TRIUMPH-1 trial, are gathering more data on how different dosage levels impact weight loss and other health outcomes in both overweight and obese individuals
A recent meta-analysis of 11 cardiovascular outcome trials involving 55,921 patients treated with GLP-1 RAs and 43,306 patients treated with DPP-4 inhibitors also revealed no significant association between either drug class and pancreatic cancer risk
First, it was reported that the mechanism of C-cell transformation in rodents is by activation of the GLP-1 receptor on the C cell, and a study has shown that GLP-1 receptor stimulation is a better predictor of C-cell hyperplasia than plasma drug concentrations of exenatide and liraglutide ( In the analysis of different types of GLP-1 receptor agonists, we found that liraglutide and dulaglutide were significantly associated with an increased risk of overall thyroid disorders